Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
January 1, 1996
Changes in E2F DNA-binding activity during induced erythroid differentiation
V M Richon, G Venta-Perez
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 1993
Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1
H Kiyokawa, V M Richon, G Venta-Perez, et al.
Cancer Research
|
July 1, 1997
Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells
V M Richon, P Russo, G Venta-Perez, et al.
The American Journal of Pathology
|
March 1, 1994
Expression of the retinoblastoma protein is regulated in normal human tissues
C Cordon-Cardo, V M Richon
Cancer Research
|
April 15, 1987
Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells
V M Richon, N Schulte, A Eastman
Oncogene
|
May 1, 1987
Expression of normal and mutant ras proteins in human acute leukemia
W P Shen, T H Aldrich, G Venta-Perez, et al.
Journal of the National Cancer Institute
|
August 3, 2000
Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells
P A Marks, V M Richon, R A Rifkind
Pharmacology & Therapeutics
|
January 1, 1996
Induced differentiation, the cell cycle, and the treatment of cancer
R A Rifkind, V M Richon, P A Marks
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
July 1, 1992
Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells
V M Richon, R A Rifkind, P A Marks
Oncogene
|
November 20, 2012
Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics
R A Copeland, M P Moyer, V M Richon
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
January 1, 1996
Changes in E2F DNA-binding activity during induced erythroid differentiation
V M Richon, G Venta-Perez
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 1993
Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1
H Kiyokawa, V M Richon, G Venta-Perez, et al.
Cancer Research
|
July 1, 1997
Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells
V M Richon, P Russo, G Venta-Perez, et al.
The American Journal of Pathology
|
March 1, 1994
Expression of the retinoblastoma protein is regulated in normal human tissues
C Cordon-Cardo, V M Richon
Cancer Research
|
April 15, 1987
Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells
V M Richon, N Schulte, A Eastman
Oncogene
|
May 1, 1987
Expression of normal and mutant ras proteins in human acute leukemia
W P Shen, T H Aldrich, G Venta-Perez, et al.
Journal of the National Cancer Institute
|
August 3, 2000
Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells
P A Marks, V M Richon, R A Rifkind
Pharmacology & Therapeutics
|
January 1, 1996
Induced differentiation, the cell cycle, and the treatment of cancer
R A Rifkind, V M Richon, P A Marks
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
July 1, 1992
Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells
V M Richon, R A Rifkind, P A Marks
Oncogene
|
November 20, 2012
Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics
R A Copeland, M P Moyer, V M Richon
Page
of 5